Viewing Study NCT04944069


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2025-12-25 @ 8:29 PM
Study NCT ID: NCT04944069
Status: UNKNOWN
Last Update Posted: 2021-06-29
First Post: 2021-05-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis
Sponsor: Second Affiliated Hospital of Nanchang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module